Home › NDC Lookup › Ingredients › Benzocaine › 45591-0002-04
🧴image loading
(from DailyMed)

Chigg Away Benzocaine 50 mg/mL Lotion, 118 mL — NDC 45591-002-04 (Billing 45591-0002-04)

by Pierson Laboratories, Inc. · 118 mL in 1 BOTTLE, PLASTIC

This is a package of 118 mL of Chigg Away Benzocaine 50 mg/mL Lotion from Pierson Laboratories, Inc., marketed since Dec 2006 and currently FDA-listed, this package's marketing is listed to end Dec 2026. It is this product's only package size.

NDC 45591-0002-04
🏷️ FDA NDC (as labeled) 45591-002-04 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Other active recalls for Benzocaine (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0602-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0605-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0601-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0603-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0604-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0606-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 45591-002-04
Product NDC 45591-002
11-digit billing NDC 45591000204
NCPDP billing unit ML — per mL (volume)
UNII U3RSY48JW5
UPC 0701277018988
Application # M017
SPL Set ID 8372e7c1-f145-4bc5-85ab-cf831abe70ce
Established class (EPC) Standardized Chemical Allergen
Physiologic effect Increased Histamine Release; Cell-mediated Immunity
Chemical class Allergens
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2006-12-01
Marketing end 2026-12-31
Route TOPICAL
Dosage form LOTION
Substance BENZOCAINE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 90859902574130
GPI class Chigg Away
GCN Seq No 007658
GCN 86800
HICL code 003339
Ingredient (HICL) Benzocaine/Sulfur
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q5
Therapeutic class — intermediate (HIC2) Agents Acting Principally On The Skin
HIC3 code Q5R
Therapeutic class — specific (HIC3) Topical Antiparasitics
AHFS code 84:04.12.00
AHFS class Scabicides And Pediculicides
FDB label name CHIGG-AWAY LOTION
FDB brand name Chigg-Away
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 007658
  • GCN: 86800
  • GPI-14 (Medi-Span): 90859902574130
  • HICL (First Databank): 003339
  • AHFS class code: 84:04.12.00
Why two NDCs? The FDA registers this code as 45591-002-04 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 45591-0002-04. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name CHIGG-AWAY LOTION Ingredient Benzocaine/Sulfur
🧪 What is this product?

Chigg Away Benzocaine 50 mg/mL Lotion is an over-the-counter topical lotion containing benzocaine, a local anesthetic. Benzocaine is typically used to numb minor skin irritation and itching when applied directly to the affected area. This product is marketed under FDA's OTC monograph rules for topical anesthetic lotions rather than as an individually approved drug application.

Supplement & herbal interactions

Some supplements/herbs that may interact with Benzocaine — tap one for details:

Dimethylsulfoxide (dmso)Moderate Turpentine OilModerate AlchemillaMinor
🌿 Every supplement checked against Benzocaine (3 interactions) — ranked by severity →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
45591-0002-04 You're viewing this Main listing 118 mL in 1 BOTTLE, PLASTIC 2006-12-01 Dec 31, 2026 Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
HIGHER CONTROL Male Climax Control Lubricating 50 mg/mL 70742-0180-02 Product 60 ml — — FDA listed —
BODY ACTION PRODUCTS Climax Control Gel 50 mg/mL 70742-0282-00 PRODUCT 60 ml — — FDA listed —
BODY ACTION PRODUCTS Endless Love for Men 50 mg/mL 70742-0284-00 PRODUCT 50 ml — — FDA listed —
BODY ACTION PRODUCTS Butt Eze Benzocaine 50 mg/mL 70742-0286-00 PRODUCT 60 ml — — FDA listed —
BODY ACTION PRODUCTS Prolong Lubricating 50 mg/mL 70742-0288-00 PRODUCT 60 ml — — FDA listed —
BODY ACTION PRODUCTS Higher Control Male Climax 50 mg/mL 70742-0292-00 PRODUCT 60 ml — — FDA listed —
Endless Love For Men 50 mg/mL 70742-0360-50 Body 50 ml — — FDA listed —
INTIMALE Benzocaine Delay Gel 50 mg/mL 81923-0369-00 SKINS 15 ml — — FDA listed —
SKINS DELAY Climax Control Benzocaine Gel 50 mg/mL 81923-0365-00 SKINS 3 ml — — FDA listed —
Chigg Away 50 mg/mLthis 45591-0002-04 Pierson 118 ml — — FDA listed —
BODY ACTION PRODUCTS Anal Glide Extra 50 mg/mL 70742-0287-00 PRODUCT 60 ml — — FDA listed —
Chigg Away 50 mg/mL 82645-0918-94 Pharma 118 ml — — FDA listed —
POWERECT Benzocaine Male Delay Gel 50 mg/mL 81923-0367-00 SKINS 3 ml — — FDA listed —
Chigg Away 50 mg/mL 82895-0857-05 Westlake 118 ml — — Discontinued —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2006
On the market since
Dec 2006
📍
2026
Currently FDA-listed
20 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerPierson Laboratories, Inc.
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code45591
First marketedDec 2006
Product typeHuman Otc Drug
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 When Using This Product 📄 Keep Out of Reach of Children 📄 Other Information 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 29 words ▾

Use s Relieves itching and discomfort due to nonpoisonous insect bites such as chiggers (redbugs), mosquitoes, ticks, and fleas, no-see-ums, biting flies, fire ants, bees and wasps; swimmers itch.

⏱️ Dosage and Administration 59 words ▾

Directions As an anti-itch: Adults and children 2 yrs. of age and over: apply topically and rub well as needed. Children under 2 years of age: Do not use. As an insect (chigger) repellent: Apply around feet, ankles, waist and to skin under all areas of tight clothing and around all openings in outer clothing. Reapply after heavy respiration.

⚠️ Warnings 76 words ▾

Warnings For external use only. Keep away from eyes or other mucous membranes. Not for prolonged use. For use on intact skin only. Do not use on children younger than 2 yrs. When using this product discontinue use if the condition persists or if rash or irritation develops and consult a doctor. As with all pesticides/drugs, keep out of reach of children. In case of accidental ingestion, contact a physician or poison control center at once.

🧪 Active Ingredient 4 words ▾

Active Ingredient Benzocaine 5%

🧪 Inactive Ingredients 23 words ▾

Inactive Ingredient Cetyl Alcohol, Glycerin, Glyceryl Stearate, Hydroxyethyl Cellulose, Isopropyl Alcohol, Methylparaben, Petrolatum, Propylparaben, Purified Water, Sodium Lauryl Sulfate, Stearic Acid, Sulfur, Triethanolamine..

🎯 Purpose 2 words ▾

Purpose Anesthetic

📄 When Using This Product 24 words ▾

When using this product discontinue use if the condition persists or if rash or irritation develops and consult a doctor. As with all pesticides/drugs,

📄 Keep Out of Reach of Children 20 words ▾

keep out of reach of children. In case of accidental ingestion, contact a physician or poison control center at once.

📄 Other Information 11 words ▾

Other Information Disposal: Do not reuse bottle. Rinse thoroughly before discarding.

📄 Package Label / Principal Display Panel 32 words ▾

PRINCIPAL DISPLAY PANEL NDC 45591-002-04 CHIGG AWAY RELIEVES ITCHING REPELS CHIGGERS 4 FL OZ (118 ML) PRINCIPAL DISPLAY PANEL NDC 45591-002-04 CHIGG AWAY RELIEVES ITCHING REPELS CHIGGERS 4 FL OZ (118 ML)

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Benzocaine — the ingredient across all brands.

Top reported reactions

Methaemoglobinaemia175
Dyspnoea103
Nausea84
Drug Hypersensitivity75
Asthenia74
Pain74
Vomiting65

Age at onset

Neonate7
Infant3
Child6
Adolescent4
Adult128
Elderly59

Reporter sex

0 reports

Serious outcomes

Hospitalization583
Life-threatening184
Death135
Disabling73
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 129 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but Pierson Laboratories, Inc. has reported a marketing end date of 2026-12-31, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Who lists this product with the FDA?
Pierson Laboratories, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 45567-0655-01 · Sun 45629-0089-01 · AVEO →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.